Indian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Indian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries i...

Benchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....

Global financial markets are experiencing a risk-off shift driven by rising sovereign bond yields, impacting equities and commodities. Mark...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Quant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...

Indian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...

JioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...

Market expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...

Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...

Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...

Bajaj Auto has announced that its board will consider a share buyback proposal on May 6, 2026, signalling plans to return surplus cash to s...

Aurobindo Pharma has initiated a share buyback program valued at Rs 800 crore, set to remain open until April 29. The company aims to reacq...